Form 8-K - Current report:
SEC Accession No. 0001299933-13-000451
Filing Date
2013-03-07
Accepted
2013-03-07 16:34:41
Documents
5
Period of Report
2013-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 LIVE FILING htm_47247.htm 8-K 20141
2 EX-99.1 exhibit1.htm EX-99.1 7083
3 EX-99.2 exhibit2.htm EX-99.2 5911
4 GRAPHIC e37882-136614524255fd5f9b_1.jpg GRAPHIC 10702
5 GRAPHIC e37882-13661453401640e263_1.jpg GRAPHIC 10702
  Complete submission text file 0001299933-13-000451.txt   64433
Mailing Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. SUITE 900 MIAMI FL 33137 305-575-6015
Opko Health, Inc. (Filer) CIK: 0000944809 (see all company filings)

EIN.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33528 | Film No.: 13673845
SIC: 2834 Pharmaceutical Preparations